NAMS
Price
$33.28
Change
-$1.98 (-5.62%)
Updated
Jul 13 closing price
Capitalization
3.89B
29 days until earnings call
Intraday BUY SELL Signals
VKTX
Price
$38.12
Change
-$0.74 (-1.90%)
Updated
Jul 13 closing price
Capitalization
4.43B
15 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NAMS vs VKTX

NAMS vs VKTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NAMS vs. VKTX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAMS is a Buy and VKTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (NAMS: $33.28 vs. VKTX: $38.12)
Brand notoriety: NAMS and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAMS: 19% vs. VKTX: 49%
Market capitalization -- NAMS: $3.89B vs. VKTX: $4.43B
NAMS [@Biotechnology] is valued at $3.89B. VKTX’s [@Biotechnology] market capitalization is $4.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAMS’s FA Score shows that 2 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • NAMS’s FA Score: 2 green, 3 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, NAMS is a better buy in the long-term than VKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAMS’s TA Score shows that 4 TA indicator(s) are bullish while VKTX’s TA Score has 5 bullish TA indicator(s).

  • NAMS’s TA Score: 4 bullish, 7 bearish.
  • VKTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VKTX is a better buy in the short-term than NAMS.

Price Growth

NAMS (@Biotechnology) experienced а -4.64% price change this week, while VKTX (@Biotechnology) price change was -1.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

NAMS is expected to report earnings on Aug 12, 2026.

VKTX is expected to report earnings on Jul 29, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($4.43B) has a higher market cap than NAMS($3.89B). VKTX YTD gains are higher at: 8.357 vs. NAMS (-5.131). NAMS has higher annual earnings (EBITDA): -214.95M vs. VKTX (-501.59M). NAMS has more cash in the bank: 636M vs. VKTX (603M). VKTX has less debt than NAMS: VKTX (0) vs NAMS (23K). NAMS has higher revenues than VKTX: NAMS (22.6M) vs VKTX (0).
NAMSVKTXNAMS / VKTX
Capitalization3.89B4.43B88%
EBITDA-214.95M-501.59M43%
Gain YTD-5.1318.357-61%
P/E RatioN/AN/A-
Revenue22.6M0-
Total Cash636M603M105%
Total Debt23K0-
FUNDAMENTALS RATINGS
VKTX: Fundamental Ratings
VKTX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
73
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NAMSVKTX
RSI
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 4 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 20 days ago
81%
Bullish Trend 20 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 12 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 4 days ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
78%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NAMS
Daily Signal:
Gain/Loss:
VKTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RXD16.52-0.03
-0.18%
ProShares UltraShort Health Care
PCLG22.00-0.14
-0.63%
Polen Focus Growth ETF
ICAP28.25-0.19
-0.68%
Infrastructure Capital Equity Income ETF
DWLD47.02-0.45
-0.95%
Davis Select Worldwide ETF
XLG61.28-0.70
-1.13%
Invesco S&P 500® Top 50 ETF